Urogen Pharma Ltd
NASDAQ:URGN

Watchlist Manager
Urogen Pharma Ltd Logo
Urogen Pharma Ltd
NASDAQ:URGN
Watchlist
Price: 22.71 USD -3.03%
Market Cap: 1.1B USD

Wall Street
Price Targets

URGN Price Targets Summary
Urogen Pharma Ltd

Wall Street analysts forecast URGN stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for URGN is 35.96 USD with a low forecast of 16.16 USD and a high forecast of 57.75 USD.

Lowest
Price Target
16.16 USD
29% Downside
Average
Price Target
35.96 USD
58% Upside
Highest
Price Target
57.75 USD
154% Upside
Urogen Pharma Ltd Competitors:
Price Targets
214450
PharmaResearch Co Ltd
86% Upside
EXAS
Exact Sciences Corp
1% Downside
KMDA
Kamada Ltd
89% Upside
NTRA
Natera Inc
7% Upside
301207
Hualan Biological Bacterin Inc
1% Upside
CHRS
Coherus BioSciences Inc
322% Upside
086900
Medy Tox Inc
13% Upside
ALEC
Alector Inc
37% Upside

Revenue
Forecast

Revenue Estimate
Urogen Pharma Ltd

The compound annual growth rate of Urogen Pharma Ltd's revenue for the next 4 years is 55%.

N/A
Past Growth
55%
Estimated Growth
Estimates Accuracy
0%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Urogen Pharma Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
1%
Average Beat

Net Income
Forecast

Net Income Estimate
Urogen Pharma Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-53%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is URGN's stock price target?
Price Target
35.96 USD

According to Wall Street analysts, the average 1-year price target for URGN is 35.96 USD with a low forecast of 16.16 USD and a high forecast of 57.75 USD.

What is Urogen Pharma Ltd's Revenue forecast?
Projected CAGR
55%

The compound annual growth rate of Urogen Pharma Ltd's revenue for the next 4 years is 55%.

Back to Top